Featured Research

from universities, journals, and other organizations

Blocking cells' movement to stop spread of cancer

Date:
July 7, 2014
Source:
University College London
Summary:
Insights into how cells move through the body could lead to innovative techniques to stop cancer cells from spreading and causing secondary tumors, finds new research. Scientists discovered that cells can change into an invasive, liquid-like state to readily navigate the narrow channels in our body. This transformation is triggered by chemical signals, which could be blocked in order to stop cancer cells from spreading.

Migrating embryonic neural crest cells. In this image, the cells are stained red for cell protrusion, yellow for cell membrane and blue for nucleus.
Credit: Prof. R. Mayor

Insights into how cells move through the body could lead to innovative techniques to stop cancer cells from spreading and causing secondary tumors, according to new UCL research.

Scientists discovered that cells can change into an invasive, liquid-like state to readily navigate the narrow channels in our body. This transformation is triggered by chemical signals, which could be blocked in order to stop cancer cells from spreading.

Most cancer deaths are not due to primary tumors, but to secondary tumors in vital organs, such as the lungs or brain, caused by cells moving from the original tumor to other places in the body.

The study led by UCL researchers and published today in the Journal of Cell Biology, used embryonic cells to investigate how groups of cells move in a developmental process similar to that used by cancer to spread around the body.

The team report a molecule called lysophosphatidic acid (LPA) changes cells from a solid-like to a liquid-like state, allowing cells to flow between normal tissues in the body. Scientists were able to switch off the signals from LPA, stopping the cells from moving down narrow, blood vessel-like channels.

Lead scientist Professor Roberto Mayor (UCL Cell & Developmental Biology), said: "We have found a way to stop the movement of embryonic cells by blocking LPA signals. It is likely that a similar mechanism operates during cancer invasion, which suggests a promising alternative in which cancer treatments might work in the future, if therapies can be targeted to limit the tissue fluidity of tumors.

"Our findings are important for the fields of cell, developmental and cancer biology. Previously, we thought cells only moved around the body either individually or as groups of well-connected cells. What we have discovered is a hybrid state where cells loosen their links to neighbouring cells but still move en masse together, like a liquid. Moreover, we can stop this movement."


Story Source:

The above story is based on materials provided by University College London. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. Kuriyama, E. Theveneau, A. Benedetto, M. Parsons, M. Tanaka, G. Charras, A. Kabla, R. Mayor. In vivo collective cell migration requires an LPAR2-dependent increase in tissue fluidity. The Journal of Cell Biology, 2014; 206 (1): 113 DOI: 10.1083/jcb.201402093

Cite This Page:

University College London. "Blocking cells' movement to stop spread of cancer." ScienceDaily. ScienceDaily, 7 July 2014. <www.sciencedaily.com/releases/2014/07/140707092655.htm>.
University College London. (2014, July 7). Blocking cells' movement to stop spread of cancer. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/07/140707092655.htm
University College London. "Blocking cells' movement to stop spread of cancer." ScienceDaily. www.sciencedaily.com/releases/2014/07/140707092655.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins